Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications.
Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications.
复制标题
DOI:
10.1186/s40580-022-00310-0
复制
发表时间:
2022-04-28
期刊:
影响因子:
11.7
通讯作者:
Lee KB
中科院分区:
文献类型:
--
作者:
Chuang ST;Conklin B;Stein JB;Pan G;Lee KB
Immunotherapy has reached clinical success in the last decade, with the emergence of new and effective treatments such as checkpoint blockade therapy and CAR T-cell therapy that have drastically improved patient outcomes. Still, these therapies can be improved to limit off-target effects, mitigate systemic toxicities, and increase overall efficacies. Nanoscale engineering offers strategies that enable researchers to attain these goals through the manipulation of immune cell functions, such as enhancing immunity against cancers and pathogens, controlling the site of immune response, and promoting tolerance via the delivery of small molecule drugs or biologics. By tuning the properties of the nanomaterials, such as size, shape, charge, and surface chemistry, different types of immune cells can be targeted and engineered, such as dendritic cells for immunization, or T cells for promoting adaptive immunity. Researchers have come to better understand the critical role the immune system plays in the progression of pathologies besides cancer, and developing nanoengineering approaches that seek to harness the potential of immune cell activities can lead to favorable outcomes for the treatment of injuries and diseases.
登录
查看更多内容
影响因子:
4.4
作者:
Chen, Wancheng;Huang, Yukai;Xiao, Yang
通讯作者:
Xiao, Yang
影响因子:
7.8
作者:
Buschmann MD;Carrasco MJ;Alishetty S;Paige M;Alameh MG;Weissman D
通讯作者:
Weissman D
影响因子:
8.6
作者:
Boks, Martine A.;Kager-Groenland, Judith R.;ten Brinke, Anja
通讯作者:
ten Brinke, Anja
影响因子:
13.6
作者:
Chen J;Qiu M;Ye Z;Nyalile T;Li Y;Glass Z;Zhao X;Yang L;Chen J;Xu Q
通讯作者:
Xu Q
影响因子:
41.2
作者:
DeMuth PC;Min Y;Huang B;Kramer JA;Miller AD;Barouch DH;Hammond PT;Irvine DJ
通讯作者:
Irvine DJ